Ładuje się......
Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus
OBJECTIVES: To identify predictors of low disease activity and clinical remission following belimumab treatment in SLE. METHODS: SLE patients who received belimumab 10 mg/kg (N = 563) in the BLISS-52 and BLISS-76 clinical trials were surveyed. The performance of baseline factors in predicting attain...
Zapisane w:
| Wydane w: | Rheumatology (Oxford) |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Oxford University Press
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880848/ https://ncbi.nlm.nih.gov/pubmed/31157891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez191 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|